Robert Horsburgh
Profiles

Charles R Horsburgh, Jr, MD

Professor, Global Health - Boston University School of Public Health

(617) 358-3758
rhorsbu@bu.edu
Crosstown Center
View Full Profile at BUMC

Biography

Dr. Horsburgh has 30 years of experience in public health and medicine. He currently holds faculty positions in the Departments of Epidemiology, Biostatistics, Global Health and Medicine. Dr. Horsburgh teaches courses in the Epidemiology of AIDS, the Epidemiology of Tuberculosis and Vaccine Epidemiology. His research focuses on tuberculosis, nontuberculous mycobacterial infections and opportunistic infections in AIDS. Currently, he is involved in research in Brazil, India, South Africa, Tanzania, Vietnam and the Philippines. He is a member of the Board of Directors of the International Union Against Tuberculosis and Lung Disease (IUATLD) and Chairman of the Steering Committee of RESIST-TB, an international organization dedicated to improving MDR-TB treatment through Clinical Trials and dissemination of best practices (www.resisttb.org).

Other Positions

  • Professor, Epidemiology - Boston University School of Public Health
  • Professor, Biostatistics - Boston University School of Public Health
  • Professor, Medicine - Boston University Chobanian & Avedisian School of Medicine

Education

  • Case Western Reserve University, MD Field of Study: Medicine
  • Yale University, MS Field of Study: Urban Studies
  • Princeton University, AB Field of Study: Architecture

Websites

Classes Taught

  • SPHEP730
  • SPHEP764
  • SPHEP784
  • SPHEP911
  • SPHGH941

Publications

  • Published on 5/20/2026

    Wijk M, Denti P, Gausi K, Myers B, Carney T, White LF, Theron D, Parry CDH, Horsburgh CR, Rawoot N, Warren RM, Court R, Kulkarni SG, Farhat MR, Buys C, Malatesta S, Weber SE, Kulkarni S, McIlleron H, Jacobson KR, Kloprogge F. Insights into the Role of Rifampicin Exposure and Clinical Baseline Covariates on the Response to Pulmonary Tuberculosis Treatment. Clin Infect Dis. 2026 May 20; 82(5):e1014-e1022. PMID: 41133922.

     Read At: PubMed
  • Published on 5/15/2026

    Campbell JI, Vachharajani O, Dubois MM, Martinez L, Christos PJ, Herlihy JM, Jenkins HE, Horsburgh CR, Jacobson KR, Powis KM. Tuberculosis in children who are HIV-exposed uninfected: A systematic review and metaanalysis. AIDS. 2026 May 15. PMID: 42138367.

     Read At: PubMed
  • Published on 5/14/2026

    Brown TS, Nelson K, Kissler S, Martinez L, Horsburgh CR, White LF, Mathema B, Jacobson KR. Understanding and exploiting superspreading to disrupt Mycobacterium tuberculosis transmission. Lancet Infect Dis. 2026 May 14. PMID: 42134384.

     Read At: PubMed
  • Published on 5/4/2026

    Gallini J, Singh UB, Dauphinais M, Sarkar S, Carwile M, Kumar R, Rao R, Chaudhary A, McQuaid CF, Maloomian K, Sinha S, Mehta S, Dowdy DW, Liu AF, Linas BP, Horsburgh CR, White LF, Sinha P. Cost-effectiveness of in-kind nutritional support for impoverished persons with tuberculosis to reduce mortality and disengagement from care in India: a modelling study. BMJ Glob Health. 2026 May 04; 11(5). PMID: 42082204.

     Read At: PubMed
  • Published on 5/1/2026

    Zheng A, Pletner E, Middelkoop K, Neilan AM, Horsburgh CR, Paltiel AD, Freedberg KA, Wood R, Reddy KP. Potential long-acting tuberculosis treatment for people with HIV: cost-effectiveness benchmarks. Ann Am Thorac Soc. 2026 May 01; 23(5):745-753. PMID: 41721756.

     Read At: PubMed
  • Published on 4/29/2026

    Malatesta S, Carney T, Niemand Wolhuter N, Overbeck V, Theron D, Weber SE, Meade CS, Thomson S, Bouton TC, Farhat M, Myers B, Wood R, Ratangee F, Horsburgh CR, White LF, Warren RM, Jacobson KR. Tuberculosis Disease Prevalence Among People Who Smoke Illicit Drugs: A Respondent- Driven Sampling Study in the Western Cape, South Africa. J Infect Dis. 2026 Apr 29; 233(4):763-772. PMID: 41060285.

     Read At: PubMed
  • Published on 3/30/2026

    Deleger JN, Khatami SN, Jones M, Jalali MS, Paltiel AD, Wong EB, Florance G, Freedberg KA, Wood R, Horsburgh CR, Reddy KP. Cost-Effectiveness of Community Tuberculosis Screening in South Africa. Am J Respir Crit Care Med. 2026 Mar 30. PMID: 42085271.

     Read At: PubMed
  • Published on 3/23/2026

    Esmail H, Thienemann F, Sossen B, Mukasa SL, Lakay F, Munro JE, Macpherson L, Warwick JM, Goliath RT, Omar-Davies N, Douglass E, Jackson A, Streicher EM, Heinsohn T, Sheerin D, Barrios MH, Aziz S, Serole KC, Daroowala R, Taliep A, Ahlers P, Malherbe ST, Bowden R, Warren RM, Walzl G, Via LE, Bahlo M, Kik SV, Ruhwald M, Jacobson KR, Horsburgh CR, Salgame P, Alland D, Barry CE, Flynn JL, Ellner JJ, Coussens AK, Wilkinson RJ. PET-CT benchmarked detection and 5-year progression of asymptomatic tuberculosis: a longitudinal, prospective cohort study. Lancet Respir Med. 2026 Mar 23. PMID: 41887246.

     Read At: PubMed
  • Published on 3/17/2026

    Rao PS, Prakash Babu S, Ezhumalai K, Knudsen S, Ramakrishnan J, Joseph N, Cintron C, Dauphinais MR, Narasimhan PB, Salgame P, Hochberg NS, Hom DL, Heysell SK, Horsburgh CR, Ellner JJ, Sinha P, Sarkar S. Rifampin Exposure in Pregnant and Nonpregnant Women With Tuberculosis in India. J Infect Dis. 2026 Mar 17; 233(3):594-597. PMID: 40925610.

     Read At: PubMed
  • Published on 2/11/2026

    Thomson S, Overbeck V, Theron D, Botha B, Malatesta S, Bouton TC, Niemand Wolhuter N, Ratangee F, Campbell JI, Cesare N, Kulkarni Goodwin S, Meade CS, Horsburgh CR, White LF, Myers B, Warren RM, Carney T, Jacobson KR. Linkage to TB and HIV care for persons who smoke illicit drugs: a prospective cohort study. IJTLD Open. 2026 Feb; 3(2):91-96. PMID: 41847680.

     Read At: PubMed

View 386 more publications:View Full Profile at BUMC

News & In the Media

View all profiles